SPRY

SPRY EBITDA Margin

-177.04%TTM

Period ending:

SPRY FY EBITDA Margin%
SPRY FY EBITDA Margin21727.31%-202691.26%
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

SPRY ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Ars Pharmaceuticals Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-198.6426%
9.3832%
-180,973.3333%
-2,611.1702%
-361.8598%
-2.596%
0%
0%

Compare ebitda margin

All SPRY financial metrics · SPRY stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.